Investigational Drug Information for LY3314814
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the drug development status for LY3314814?
LY3314814 is an investigational drug.
There have been 12 clinical trials for LY3314814.
The most recent clinical trial was a Phase 1 trial, which was initiated on March 15th 2017.
The most common disease conditions in clinical trials are Alzheimer Disease, Dementia, and Renal Insufficiency. The leading clinical trial sponsors are AstraZeneca, Eli Lilly and Company, and [disabled in preview].
There are six US patents protecting this investigational drug and one hundred and twenty international patents.
Summary for LY3314814
| US Patents | 6 |
| International Patents | 120 |
| US Patent Applications | 21 |
| WIPO Patent Applications | 1 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 1 (2017-03-15) |
| Vendors | 25 |
Recent Clinical Trials for LY3314814
| Title | Sponsor | Phase |
|---|---|---|
| A Study of LY3314814 in Participants With Liver Impairment | AstraZeneca | Phase 1 |
| A Study of LY3314814 in Participants With Liver Impairment | Eli Lilly and Company | Phase 1 |
| A Study of Lanabecestat in Healthy Female Participants Taking Oral Contraceptive | AstraZeneca | Phase 1 |
Clinical Trial Summary for LY3314814
Top disease conditions for LY3314814
Top clinical trial sponsors for LY3314814
US Patents for LY3314814
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| LY3314814 | ⤷ Try a Trial | Compounds and their use as BACE inhibitors | AstraZeneca AB (Sodertalje, SE) | ⤷ Try a Trial |
| LY3314814 | ⤷ Try a Trial | Camsylate salt | ASTRAZENECA AB (Sodertalje, SE) | ⤷ Try a Trial |
| LY3314814 | ⤷ Try a Trial | Compounds and their use as BACE inhibitors | AstraZeneca AB (Sodertalje, SE) | ⤷ Try a Trial |
| LY3314814 | ⤷ Try a Trial | Compounds and their use as BACE inhibitors | Astrazeneca AB (Sodertalje, SE) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for LY3314814
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| LY3314814 | Argentina | AR084553 | 2030-12-22 | ⤷ Try a Trial |
| LY3314814 | Argentina | AR107709 | 2030-12-22 | ⤷ Try a Trial |
| LY3314814 | Australia | AU2011345389 | 2030-12-22 | ⤷ Try a Trial |
| LY3314814 | Australia | AU2016200538 | 2030-12-22 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
